Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT)

Lancet. 2005 Aug 27-Sep 2;366(9487):763-73. doi: 10.1016/S0140-6736(05)67182-6.

Abstract

DDT (bis[4-chlorophenyl]-1,1,1-trichloroethane) is a persistent insecticide that was used worldwide from the mid 1940s until its ban in the USA and other countries in the 1970s. When a global ban on DDT was proposed in 2001, several countries in sub-Saharan Africa claimed that DDT was still needed as a cheap and effective means for vector control. Although DDT is generally not toxic to human beings and was banned mainly for ecological reasons, subsequent research has shown that exposure to DDT at amounts that would be needed in malaria control might cause preterm birth and early weaning, abrogating the benefit of reducing infant mortality from malaria. Historically, DDT has had mixed success in Africa; only the countries that are able to find and devote substantial resources towards malaria control have made major advances. DDT might be useful in controlling malaria, but the evidence of its adverse effects on human health needs appropriate research on whether it achieves a favourable balance of risk versus benefit.

Publication types

  • Review

MeSH terms

  • Africa South of the Sahara
  • Animals
  • DDT / adverse effects*
  • DDT / pharmacokinetics
  • Environmental Exposure
  • Humans
  • Insecticides / adverse effects*
  • Insecticides / pharmacokinetics
  • Malaria / prevention & control*
  • Mosquito Control*

Substances

  • Insecticides
  • DDT